Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-003081

Chief Financial Officer sold 20,000 shares at $29.87 ($597,400)

  • Chief Financial Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Chad M · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-01-08 Exercise or conversion : show line 1 in the form +20,000 $4.07 $81,400 21,000 D
2020-01-08 Sale : show line 2 in the form −20,000 $29.87 $597,400 1,000 D
Open-market sales · 20,000 sh · avg $29.87 · $597,400

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-01-08 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −20,000 80,000 D
Loading xslF345X03/doc4.xml…